Bioanalysis

Papers
(The median citation count of Bioanalysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis27
A Brave New World?27
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery27
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration25
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO25
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy24
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population22
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox22
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies20
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid19
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar19
Adopting ambient ionization mass spectrometry into bioanalytical laboratories19
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations18
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference17
High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study17
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique14
Validation of Enantioseparation and Quantitation of an Active Metabolite of Abrocitinib in Human Plasma14
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group13
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics13
Lot-to-lot Reproducibility, Stability and Life Cycle Management of Antibody Reagents for Flow Cytometry13
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients12
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma12
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses12
Special Focus Issue - Covid-19: Bioanalytical Considerations, Contributions and Lessons – Part 211
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis11
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS11
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA11
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma11
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani11
Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies10
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification10
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers9
Determination of meropenem in capillary plasma microsamples using LC–MS/MS9
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency9
Highlights of the 13th Japan Bioanalysis Forum Symposium9
Bioanalysis Rising Star Award 2024: interviews with the finalists9
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS9
Highlights of the 15th Japan Bioanalysis Forum Symposium8
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements8
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients8
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum8
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System8
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled8
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays8
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations8
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers8
Olympic Anti-Doping Laboratory: The Analytical Technological Road From 2016 Rio De Janeiro to 2021 Tokyo8
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing8
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics7
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider7
An Integrated Outsourcing Practice of Nonclinical LC–MS Bioanalysis and Toxicokinetics at Novartis small Molecule Drug Development7
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing7
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond7
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS7
Chemical Derivatization in Combination with Supercritical Fluid Chromatography to Improve Resolution of Stereoisomers7
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin7
Current and Effective Strategies for Critical Reagent Characterization, Storage, Stability, Retesting and Life Cycle Management for Ligand-Binding Assays and Flow Cytometry7
COVID-19’s Impact on Bioanalytical Labs7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers7
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study6
Special Focus Issue - Performing Flow Cytometry in Clinical Trials6
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma6
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications6
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe6
Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development6
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten6
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery6
Greener Bioanalytical Sample Preparation. What is Next?6
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry6
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis6
Biopharmaceutical Quality Control with Mass Spectrometry6
Solid-Phase Microextraction for Assessment of Plasma Protein Binding, a Complement to Rapid Equilibrium Dialysis5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats5
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis5
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform5
Quantitation of Ivosidenib in Human Plasma Via LC–MS/MS and its Application in Clinical Trials5
Validation of High-Throughput, Semiquantitative Solid-Phase Sarscoronavirus-2 Serology Assays in Serum and Dried Blood Spot Matrices5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma5
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV5
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study5
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy5
Validation of an HPLC Method for Estimation of Cefotaxime from Dried Blood Spot: Alternative to Plasma-Based PK Evaluation in Neonates5
Advancements in Practical and Scientific Bioanalytical Approaches to Metabolism Studies in Drug Development5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications5
Multidimensional Chromatography Platforms: Status and Prospects5
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective5
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates5
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development5
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies4
Cloud Solutions for GxP Laboratories: Considerations for Data Storage4
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management4
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription4
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu4
Simultaneous Quantification of Oxcarbazepine and Its Active Metabolite in Spiked Human Plasma Using Ultra Performance Liquid Chromatography–MS/MS4
Thyroxine Biosensors: A Review on Progress and Challenges4
Harmonization of Vaccine Ligand Binding Assays Validation4
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective4
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling4
Quantitative Determination of Cpd118, A Novel FBPase Inhibitor, in Dog Plasma by HPLC–MS/MS4
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides4
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study4
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control4
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis4
High-resolution mass spectrometry for glycoproteomics4
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents4
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid4
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis4
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel4
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps4
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats4
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS3
Bioanalysis Rising Star Award 2023: announcing our finalists3
Lessons Learned from the COVID-19 Pandemic and its Impact on Bioanalysis and Drug Development3
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development3
Research progress of N -nitrosamine detection methods: a review3
Analytical Comparison of ELISA and Mass Spectrometry for Quantification of Serum Hepcidin in Critically Ill Patients3
Large Molecule Bioanalysis by LC–MS: Beyond Simply Quantifying3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables3
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes3
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood3
Determination of Levofloxacin by HPLC with Fluorescence Detection in Human Breast Milk3
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum3
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment3
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics3
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts3
China's NMPA Perspective on the Clinical Performance of SARS-CoV-2 Antigen Test Reagents3
Welcome to Volume 14 of Bioanalysis3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview3
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring3
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories3
Nitrosamine Impurities: from Raw Materials to Final Drug Product3
A Bioanalytical Screening Method for Enterococcus faecalis RNPP-type Quorum Sensing Peptides in Murine Feces3
Detection of Sars-Cov-2At the Point of Care3
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk3
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population3
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum3
High-Throughput MS for Intact Protein Analysis3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio3
Analytical Considerations to Support Expeditious Formulation Development of Vaccines3
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?3
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode3
Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples2
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics2
Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children2
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective2
Evaluation of the light-initiated chemiluminescence assay for quantification of Humulus scandens pollen - specific IgE2
Solutions for Hematocrit Bias in Dried Blood Spot Hormone Analysis2
Development and Validation of an LC-MS/MS Method for Determination of a Novel Anticancer Agent (CPI-613) in HumanPlasma2
An Ultrasensitive LC–MS/MS Method and Application to Clinical Dose-Range Finding for Glycopyrrolate via an e-Nebulizer2
pH-induced Homogeneous liquid–liquid Microextraction Method based on new Switchable Deep Eutectic Solvent for the Extraction of Three Antiepileptic Drugs from Breast Milk2
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS2
The Biomarker Bandwagon's Quantitative Quandary: 10 years of Tuning2
Comparison of Liquid–Liquid Extraction, Microextraction and Ultrafiltration for Measuring Free Concentrations of Testosterone and Phenytoin2
Effective Biomarker Measurement is Key for Biotherapeutic Development2
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization2
Testing in the Workplace: Finding a Path Through a Pandemic2
Lacidipine: Review of Analytical Methods Developed for Pharmaceutical Dosage forms and Biological Fluids2
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis2
Sensitive LC-MS/MS Quantification of Unconjugated Maytansinoid DM4 and its Metabolite S-methyl-DM4 in Human Plasma2
Volumetric Absorptive Microsampling: Its Use in Covid-19 Research and Testing2
Highlights of the 14th Japan Bioanalysis Forum Symposium2
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices2
Immunoassay Automation is Driving Advancements in Cell and Gene Therapies2
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay2
WRIB Poster Awards Winners 20242
A Simple Isotope-Labeled UHPLC–MS/MS Assay for Simultaneous Quantification of Methotrexate, Imatinib and Dasatinib2
Surrogate Peptide Selection and Internal Standardization for Accurate Quantification of Endogenous Proteins2
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline2
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies2
Approaches to Overcome the Challenge of Sample Stability for Flow Cytometry Analysis in Clinical Trials2
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma2
Analytical Techniques for Monitoring of Toluene and Xylene Exposure Biomarkers Hippuric Acid and Methylhippuric Acid in Human Urine Samples2
A Competitive Ligand-Binding Assay to Detect Neutralizing Antibodies to a Bispecific Drug Using a Multiplex Meso Scale Discovery Platform2
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis2
LC–MS/MS Bioanalytical Method for Quantification of Binimetinib and Venetoclax, and their Pharmacokinetic Interaction2
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment2
With Great Power Comes Great Responsibility: High-Dimensional Spectral Flow Cytometry to Support Clinical Trials2
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood2
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover2
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples2
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices2
Meet the Editorial Board: An Introduction to and Insights from Fumin Li2
Development of a UPLC–MS/MS Method for Determination of a Dual EZH1/2 Inhibitor UNC1999 in Rat Plasma2
Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?2
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga2
A Flow Cytometric Journey Into Cell Cycle Analysis2
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment2
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study2
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies2
Observations from a decade of oligonucleotide bioanalysis by LC-MS2
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena2
Considerations for Drug Development Biomarker Assays in the Clinical Laboratory2
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?2
Conference report for the 10th China Bioanalysis Forum annual meeting2
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; 2
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay2
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS2
LC-MS/MS Methods to quantify HCP002 in Human Plasma and Urine: Applications in a Pharmacokinetic Study2
A Cell-Based FcRn-dependent Recycling assay for Predictive Pharmacokinetic assessment of Therapeutic Antibodies2
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography2
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica2
Analytical Considerations for Reducing the Matrix Effect for the Sphingolipidome Quantification in Whole Blood2
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics2
A novel biomarker assay qualification strategy for rare human matrices – a case study of biomarkers in aqueous humor1
Quantitation of anacetrapib in human and animal adipose by liquid chromatography with mass spectrometric detection1
Bioanalytical LC–MS/MS method for simultaneous estimation of atorvastatin, its major active metabolites and ezetimibe1
A green bioanalytical spectrofluorimetric approach for estimation of Avapritinib anti-tumor drug; application to quality control and clinical studies1
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients1
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum com1
Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry1
Multi-Laboratory Evaluation of Immunoaffinity LC–MS-Based Glucagon-Like Peptide-1 Assay1
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis1
Bioanalytical method validation and sample analysis for nirmatrelvir in dried blood collected using the Tasso-M20 device1
Challenges with Development of a Pharmacokinetics Assay to Measure a Variably Glycosylated Fusion Protein1
The role of Ligand-Binding Assay and LC–MS in the Bioanalysis of Complex Protein and Oligonucleotide Therapeutics1
Understanding Drug–Protein Binding and ADME Studies for DMPK1
Towards Identifying Nicomorphine Administration in Doping Control: Synthesis of Metabolites1
Remote Audits: A CRO Virtual Reality – What Lessons have been Learned in a Time of Unexpected Isolation1
Overcoming Challenges Associated with the Bioanalysis of Cysteine-Conjugated Metabolites in the Presence of Antibody–Drug Conjugates1
Assessing prognosis by quantifying FcγRIIa on fixed platelets1
Development of a Sensitive HPLC Method with Fluorescence Detection for the Determination of Motilin in Human Plasma1
Ultrasensitive Digital Immunoassays for SOD1 Conformation in Amyotrophic Lateral Sclerosis1
A New Approach with Dried Plasma Spots: A Rapid Determination of Antidepressants and Antipsychotics by Fast GC–MS1
Quantitation of Vistusertib by UHPLC-MS/MS in Rat Plasma and its Application to a Pharmacokinetic Study1
An insight into the presence of impurities in reference standards and their impact on mass spectrometry-based bioanalysis1
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability &1
Green Sample Preparation in Bioanalysis: Where Are We Now?1
Development of an Immunoassay for Aglycosylated Murine IgG1 in Mouse Serum via Generation of a Specific Tool Antibody1
A Sensitive LC–MS/MS Assay to Quantitate Free Payload Aur0101 from ADC PYX-201 in Rat and Monkey Plasma1
Simultaneous Determination of Duloxetine and 4-Hydroxy Duloxetine Glucuronide in Human Plasma and Back-Conversion Study1
Feedback From the Science Café At the 7Th European Bioanalysis Forum Young Scientist Symposium1
Running the Assay of 2023 and Introducing Bioanalysis volume 161
Monitoring of Hemoglobin and Erythropoiesis-Related mRNA with Dried Blood Spots in Athletes and Patients1
Development and multicenter validation of an LC–MS-based bioanalytical method for antisense therapeutics1
WRIB Poster Awards Winners 20231
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor1
UHPLC-MS/MS for Plasma Lamotrigine Analysis and Comparison with a Homogenous Enzyme Immunoassay1
Bioanalysis of the Bicycle®Toxin Conjugate BT5528 and Released Monomethyl Auristatin E via Liquid Chromatography–Tandem Mass Spectrometry1
Development of Fe 3 O 4 /Reduced Graphene Oxide Nanocomposite-Based Dispersive Solid-Phase Extraction for the Quantification of Fi1
Risk-Based Approach of Bioanalytical Methods for Clinical Immunogenicity Assessment of Multidomain Biotherapeutics1
Regen-Cov ® Antibody Cocktail Bioanalytical Strategy: Comparison of Lc-Mrm-Ms and Immunoassay Methods for Drug Quantification1
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Nigel Phillip Danielson-Ewing1
0.066256999969482